Benchmark Investment Advisors’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,527
Closed -$265K 87
2024
Q3
$265K Hold
2,527
0.19% 75
2024
Q2
$359K Sell
2,527
-1,730
-41% -$199K 0.26% 68
2024
Q1
$475K Buy
4,257
+100
+2% +$11.9K 0.37% 60
2023
Q4
$539K Buy
+4,157
New +$573K 0.5% 53

Other funds holding ACLS

Benchmark Investment Advisors's ACLS Position: Q4 2024 in Review

Benchmark Investment Advisors sold out of Axcelis (ACLS) in Q4 2024, closing a stake of 2,527 shares — an estimated $265K sold.

Benchmark Investment Advisors first reported a position in ACLS in Q4 2023 and held it in 4 quarters. The position peaked at $539K in Q4 2023. 322 funds tracked by Wall St. Rank hold ACLS as of Q4 2024.

  • Benchmark Investment Advisors reported no remaining Axcelis position as of Q4 2024 after selling out during the quarter.
  • Benchmark Investment Advisors sold 2,527 Axcelis shares in Q4 2024, an estimated $265K.
  • Benchmark Investment Advisors first reported a position in Axcelis in Q4 2023 and held it in 4 quarters.
  • Benchmark Investment Advisors's Axcelis position peaked at $539K in Q4 2023.
  • 322 funds tracked by Wall St. Rank held Axcelis as of Q4 2024.

Based on Benchmark Investment Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.